Lannett Launches Authorized Generic of Tirosint(R) (Levothyroxine Sodium Capsules)

Unique Oral Formulation of Levothyroxine Expands Thyroid Deficiency Product Portfolio PHILADELPHIA, Nov. 3, 2020 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has commenced the launch of the auth... Biopharmaceuticals, Generics, Product Launch Lannnett, Tirosint, levothyroxine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news